Research Paper Volume 15, Issue 4 pp 1199—1209

Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke

class="figure-viewer-img"

Figure 2. Serum YKL-40 levels in different groups according to (A) poor outcome, (B) all-cause mortality and (C) recurrent stroke in AIS patients. Mann-Whitney U Test. Horizontal lines represent medians and interquartile ranges (IQRs).